1. Current Studies of Aspirin as an Anticancer Agent and Strategies to Strengthen its Therapeutic Application in Cancer
   Phuong H.L. Tran et al, 2021, Current Pharmaceutical Design CrossRef
2. Parecoxib: an Enhancer of Radiation Therapy for Colorectal Cancer
   Wei Xiong et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
3. EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
   Arafa Musa et al, 2022, Molecules CrossRef
4. A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells
   Z. Lin et al, 2016, Molecular BioSystems CrossRef
5. (−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer
   Abu Bakar Siddique et al, 2020, Nutrients CrossRef
6. Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia
   Sisi Liu et al, 2016, Endocrine-Related Cancer CrossRef
7. Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects
   Emmanouil Saloustros et al, 2017, Molecular and Cellular Endocrinology CrossRef
8. Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
   Petra Party et al, 2021, Pharmaceutics CrossRef
9. Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel “Nano-in-Micro” Structured Dry Powder Inhaler System
   Petra Party et al, 2023, Micromachines CrossRef
10. The selective cyclooxygenase‐2 inhibitor mavacoxib (Trocoxil) exerts anti‐tumour effects in vitro independent of cyclooxygenase‐2 expression levels
    Emma A. Hurst et al, 2019, Veterinary and Comparative Oncology CrossRef